Using proton pump inhibitors increases the risk of hepato-biliary-pancreatic cancer. A systematic review and meta-analysis

Background: More and more studies are focusing on the adverse effects and damage caused by PPI abuse, we carried out a systematic review and meta-analysis for assessing whether the proton pump inhibitor (PPI) leads to hepato-biliary-pancreatic cancer. Methods: PubMed, EMBASE and Web of Science were...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Wence, Chen, Xinlong, Fan, Qigang, Yu, Haichuan, Jiang, Wenkai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515471/
https://www.ncbi.nlm.nih.gov/pubmed/36188583
http://dx.doi.org/10.3389/fphar.2022.979215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515471/
https://www.ncbi.nlm.nih.gov/pubmed/36188583
http://dx.doi.org/10.3389/fphar.2022.979215

Ejemplares similares